Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences being held in February and March.

Guggenheim SMID Cap Biotech Conference

  Format: Fireside chat and 1×1 meetings
  Date/time: Wednesday, February 5 at 10:30 a.m. ET
  Location: New York, NY
  Webcast link: https://wsw.com/webcast/guggen2/gpcr/2003892
     

Leerink Global Healthcare Conference

  Format: Fireside chat and 1×1 meetings
  Date/time: Monday, March 10 at 1:00 p.m. ET
  Location: Miami, FL
  Webcast link: https://wsw.com/webcast/leerink38/gpcr/2218364
     

Jefferies Biotech on the Bay Summit

  Format: 1×1 meetings
  Date: Tuesday, March 11
  Location: Miami, FL
     

The live and archived webcasts of the fireside chats will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for 90 days.

About Structure Therapeutics 
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.

Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com

Media:
Dan Budwick
1AB
Dan@1abmedia.com

Staff

Recent Posts

Rapid Dose Announces Proposed Debt Settlement

Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

4 hours ago

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES QUARTERLY DIVIDEND INCREASE

GLEN ALLEN, Va., May 9, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) (the…

5 hours ago

Auguste Escoffier School of Culinary Arts Earns Great Place To Work-Certified™ Status for Sixth Consecutive Year

SCHAUMBURG, Ill., May 9, 2025 /PRNewswire/ -- For the sixth year in a row, Auguste…

5 hours ago

Dr. Christina Rahm’s Merci Dupre Clothiers Presents Revolutionary Eco-Fashion Show Tonight in Spartanburg, SC

Spartanburg, South Carolina--(Newsfile Corp. - May 9, 2025) - Dr. Christina Rahm, renowned scientist, humanitarian,…

8 hours ago

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one…

10 hours ago